NCT00341497

Brief Summary

The purpose is to determine the extent of genetic damage in oral mucosal lesions ascertained in the study, whether specific genotypes are associated with genetic damage observed in the oral mucosal lesions, whether the extent of genetic damage changes over time, and what factors (e.g. smoking) contribute to those changes. Genetic damage indicators will include among others DNA adduct formation, particularly related to tobacco smoke carcinogens such as polycyclic aromatic hydocarbons. The genotypes of interest will be focused on these affecting carcinogen metabolism, (e.g., (CYP family), but may also include those related to growth factors, cell cycle control, and DNA repair. Microsatellite instability is another key indicator of damage that we plan to examine. This study was undertaken due to the paucity of data on the types of oral lesions seen in general dental practice and the limited knowledge of the natural history of these lesions. Persons were enrolled who had red and/or white oral lesions identified at 6 Dental Clinics at VA Medical Centers. The VA Centers involved were: Washington, DC; Atlanta, GA; Durham, NC; San Francisco, CA; Danville, IL; and San Antonio, TX. When a dentist found a red or white lesions in the course of routine outpatient examinations and care, obvious causes such as denture frictional lesions could be ruled out, and the normal standard of care for the lesion was biopsy, the patient was considered for enrollment into the study. The study was described to the patient, the consent for was signed, the patient received an intraoral examination to identify and characterize the oral lesions, the lesions were photographed, an oral epithelial cell sample was taken from the site and from the rest of the oral mucosa, and the patient was interviewed using a standard questionnaire that requested information about sociodemograhic, medical, and lifestyle factors, particularly tobacco and alcohol use all as part of the study protocol, and the patient received a biopsy as part of normal care. The biopsy report was obtained as was a small piece of the biopsy material that was not needed for patient diagnostic purposes. The subjects returned every 4-6 months for reassessment of the lesion or to determine that the lesion had not returned. The patients completed a questionnaire at each of these visits so that lifestyle factors such as tobacco and alcohol use could be reassessed. Also oral epithelial cell scrapings were obtained at each of these visits. This study is particularly valuable because longitudinal data was collected and because the data were collected over time using standard procedures.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
80

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Aug 1996

Longer than P75 for all trials

Geographic Reach
1 country

6 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 28, 1996

Completed
9.8 years until next milestone

First Submitted

Initial submission to the registry

June 19, 2006

Completed
2 days until next milestone

First Posted

Study publicly available on registry

June 21, 2006

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 4, 2006

Completed
18.8 years until next milestone

Study Completion

Last participant's last visit for all outcomes

July 29, 2025

Completed
Last Updated

July 31, 2025

Status Verified

July 1, 2025

Enrollment Period

10.1 years

First QC Date

June 19, 2006

Last Update Submit

July 29, 2025

Conditions

Keywords

LeukoplakiaOral MucosaBiomarkersNatural History

Outcome Measures

Primary Outcomes (2)

  • New or re-emergence of oral lesion

    the natural history of the oral lesions was assessed via clinical examination over a period of 4 years

    Annually

  • oral cancer diagnosis

    Assessed via medical record

    Once

Study Arms (1)

Cohort

Persons seen at dental clinics at 6 Veterans Affairs Medical Centers who had clinically visibleoral lesions

Eligibility Criteria

Age18 Years - 110 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Persons seen at dental clinics at 6 Veterans Affairs Medical Centers who had clinically visible oral lesions@@@

You may qualify if:

  • Patients with white, red, or white and red lesions in the oral cavity and oropharynx as identified by the participating dentist.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (6)

U.C.S.F./ Vterans Affairs Medical Center

San Francisco, California, 94143, United States

Location

VA Medical Center, Washington D.C.

Washington D.C., District of Columbia, 20422, United States

Location

VA Medical Ctr, Atlanta

Atlanta, Georgia, United States

Location

Veterans Affairs, Danville

Danville, Illinois, United States

Location

VA Medical Center, Durham

Durham, North Carolina, United States

Location

Veterans Affairs, San Antonio

San Antonio, Texas, United States

Location

Related Publications (3)

  • Bouquot JE, Gorlin RJ. Leukoplakia, lichen planus, and other oral keratoses in 23,616 white Americans over the age of 35 years. Oral Surg Oral Med Oral Pathol. 1986 Apr;61(4):373-81. doi: 10.1016/0030-4220(86)90422-6.

    PMID: 3458148BACKGROUND
  • Brachman DG, Graves D, Vokes E, Beckett M, Haraf D, Montag A, Dunphy E, Mick R, Yandell D, Weichselbaum RR. Occurrence of p53 gene deletions and human papilloma virus infection in human head and neck cancer. Cancer Res. 1992 Sep 1;52(17):4832-6.

    PMID: 1324797BACKGROUND
  • Brennan JA, Boyle JO, Koch WM, Goodman SN, Hruban RH, Eby YJ, Couch MJ, Forastiere AA, Sidransky D. Association between cigarette smoking and mutation of the p53 gene in squamous-cell carcinoma of the head and neck. N Engl J Med. 1995 Mar 16;332(11):712-7. doi: 10.1056/NEJM199503163321104.

    PMID: 7854378BACKGROUND

MeSH Terms

Conditions

Lichen PlanusLeukoplakia, OralMouth NeoplasmsLeukoplakia

Condition Hierarchy (Ancestors)

Lichenoid EruptionsSkin Diseases, PapulosquamousSkin DiseasesSkin and Connective Tissue DiseasesHead and Neck NeoplasmsNeoplasms by SiteNeoplasmsPrecancerous ConditionsMouth DiseasesStomatognathic DiseasesPathological Conditions, AnatomicalPathological Conditions, Signs and Symptoms

Study Officials

  • Eva Szabo, M.D.

    National Cancer Institute (NCI)

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
NIH
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 19, 2006

First Posted

June 21, 2006

Study Start

August 28, 1996

Primary Completion

October 4, 2006

Study Completion

July 29, 2025

Last Updated

July 31, 2025

Record last verified: 2025-07

Locations